Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol for sedation during endobronchial ultrasound bronchoscopy
2015-001110-97Phase 4Completed
- Sponsor
- Parc de Salut Mar
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in bronchial carcinoma (2 arms), sponsored by Parc de Salut Mar. Primary endpoint: Incidence of desaturation. Started Apr 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on 2015-001110-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001110-97.